# Repaglinide

NDC: 60687-560
Generic name: Repaglinide
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200917

FDA application: ANDA203820

## Active ingredients

- REPAGLINIDE: 1 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-560"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-560
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=dd1d8337-9903-4b8a-a9ea-569e4d134e74